LCAR-HL30
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LCAR-HL30, covering 2024-07-10 to 2024-07-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma [Phase 1]